Clinical Trials Directory

Trials / Sponsors / Repurposed Therapeutics, Inc.

Repurposed Therapeutics, Inc.

Industry · 11 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
CompletedEfficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
Motion Sickness
Phase 32022-08-23
RecruitingCombination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sicknes
Motion Sickness, Space, Motion Sickness, Sea Sickness
Phase 22022-01-21
RecruitingCombination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sicknes
Motion Sickness, Space, Motion Simulation, Parabolic Flight
Phase 22021-08-10
CompletedNasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
Motion Sickness
Phase 32021-06-14
CompletedNasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
Motion Sickness
Phase 32019-06-09
CompletedPrevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
Motion Sickness
Phase 32019-06-07
CompletedThe Prevention and Treatment of Nausea Associated With Motion Sickness
Motion Sickness
Phase 32019-04-26
UnknownNasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness
Motion Sickness
Phase 32019-04-22
UnknownScopolamine in Healthy Volunteers
Major Depressive Disorder (MDD)
Phase 12018-08-01
TerminatedDPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness
Motion Sickness
Phase 2 / Phase 32018-06-29
TerminatedPharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray
Motion Sickness
Phase 2 / Phase 32014-06-01